|
G |
ABCB1 |
ATP binding cassette subfamily B member 1 |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of ABCB1A mRNA; trimethylarsine oxide results in increased expression of ABCB1A protein |
CTD |
PMID:16436460 |
|
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
|
|
G |
ABCC1 |
ATP binding cassette subfamily C member 1 (ABCC1 blood group) |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of ABCC1 mRNA; trimethylarsine oxide results in increased expression of ABCC1 protein |
CTD |
PMID:16436460 |
|
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of ABCC2 mRNA; trimethylarsine oxide results in increased expression of ABCC2 protein |
CTD |
PMID:16436460 |
|
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
|
|
G |
ABCC3 |
ATP binding cassette subfamily C member 3 |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of ABCC3 mRNA; trimethylarsine oxide results in increased expression of ABCC3 protein |
CTD |
PMID:16436460 |
|
NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
|
|
G |
AHR |
aryl hydrocarbon receptor |
multiple interactions |
ISO EXP |
trimethylarsine oxide affects the localization of and results in increased activity of AHR protein AHR mutant form inhibits the reaction [trimethylarsine oxide results in increased expression of CYP1A1 protein]; trimethylarsine oxide results in decreased expression of and affects the localization of AHR protein |
CTD |
PMID:24161444 PMID:26144063 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
ALDH1A1 |
aldehyde dehydrogenase 1 family member A1 |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:17481689 |
|
NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442
|
|
G |
AS3MT |
arsenite methyltransferase |
increases chemical synthesis multiple interactions |
ISO |
AS3MT protein results in increased chemical synthesis of trimethylarsine oxide Glutathione affects the reaction [AS3MT protein results in increased chemical synthesis of trimethylarsine oxide] |
CTD |
PMID:15606138 |
|
NCBI chr10:102,869,470...102,901,899
Ensembl chr10:102,869,470...102,901,899
|
|
G |
CASP3 |
caspase 3 |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of CASP3 mRNA |
CTD |
PMID:17481689 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CCND1 |
cyclin D1 |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of CCND1 mRNA |
CTD |
PMID:17481689 |
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
CCNE1 |
cyclin E1 |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of CCNE1 mRNA |
CTD |
PMID:17481689 |
|
NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,991...29,824,312
|
|
G |
CDH1 |
cadherin 1 |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of CDH1 mRNA |
CTD |
PMID:17481689 |
|
NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
|
|
G |
CDH2 |
cadherin 2 |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of CDH2 mRNA |
CTD |
PMID:17481689 |
|
NCBI chr18:27,932,879...28,177,130
Ensembl chr18:27,932,879...28,177,946
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
affects expression increases expression multiple interactions |
ISO EXP |
trimethylarsine oxide affects the expression of CYP1A1 mRNA trimethylarsine oxide results in increased expression of CYP1A1 mRNA; trimethylarsine oxide results in increased expression of CYP1A1 protein trimethylarsine oxide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A1 protein]; trimethylarsine oxide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; trimethylarsine oxide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein]; trimethylarsine oxide results in increased expression of and results in increased activity of CYP1A1 protein AHR mutant form inhibits the reaction [trimethylarsine oxide results in increased expression of CYP1A1 protein]; trimethylarsine oxide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A1 protein]; trimethylarsine oxide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; trimethylarsine oxide results in increased expression of and results in increased activity of CYP1A1 protein |
CTD |
PMID:17481689 PMID:24161444 PMID:26042454 PMID:26144063 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP1A2 |
cytochrome P450 family 1 subfamily A member 2 |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of CYP1A2 mRNA trimethylarsine oxide results in increased expression of CYP1A2 mRNA; trimethylarsine oxide results in increased expression of CYP1A2 protein |
CTD |
PMID:17481689 PMID:26144063 |
|
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
|
|
G |
CYP1B1 |
cytochrome P450 family 1 subfamily B member 1 |
multiple interactions increases expression |
ISO |
trimethylarsine oxide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1B1 protein]; trimethylarsine oxide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA]; trimethylarsine oxide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 protein]; trimethylarsine oxide results in increased expression of and results in increased activity of CYP1B1 protein trimethylarsine oxide results in increased expression of CYP1B1 mRNA |
CTD |
PMID:26042454 PMID:26144063 |
|
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
|
|
G |
CYP2C18 |
cytochrome P450 family 2 subfamily C member 18 |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of CYP2C11 mRNA |
CTD |
PMID:17481689 |
|
NCBI chr10:94,683,729...94,736,190
Ensembl chr10:94,683,729...94,736,190
|
|
G |
DNMT1 |
DNA methyltransferase 1 |
decreases expression |
ISO |
trimethylarsine oxide results in decreased expression of DNMT1 mRNA |
CTD |
PMID:17481689 |
|
NCBI chr19:10,133,346...10,194,953
Ensembl chr19:10,133,342...10,231,286
|
|
G |
FASLG |
Fas ligand |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of FASLG mRNA |
CTD |
PMID:17481689 |
|
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
|
|
G |
GJB1 |
gap junction protein beta 1 |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of GJB1 mRNA |
CTD |
PMID:17481689 |
|
NCBI chr X:71,215,239...71,225,516
Ensembl chr X:71,212,811...71,225,516
|
|
G |
GSTA2 |
glutathione S-transferase alpha 2 |
decreases expression increases expression |
ISO |
trimethylarsine oxide results in decreased expression of GSTA2 mRNA; trimethylarsine oxide results in decreased expression of GSTA2 protein trimethylarsine oxide results in increased expression of GSTA2 mRNA |
CTD |
PMID:16436460 PMID:17481689 |
|
NCBI chr 6:52,750,087...52,763,475
Ensembl chr 6:52,750,087...52,763,475
|
|
G |
GSTA3 |
glutathione S-transferase alpha 3 |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of GSTA1 mRNA |
CTD |
PMID:26144063 |
|
NCBI chr 6:52,896,646...52,909,698
Ensembl chr 6:52,896,639...52,909,698
|
|
G |
GSTM1 |
glutathione S-transferase mu 1 |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of GSTM1 mRNA; trimethylarsine oxide results in increased expression of GSTM1 protein |
CTD |
PMID:16436460 |
|
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
|
|
G |
GSTP1 |
glutathione S-transferase pi 1 |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of GSTP1 mRNA |
CTD |
PMID:17481689 |
|
NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
|
|
G |
HMOX1 |
heme oxygenase 1 |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of HMOX1 mRNA; trimethylarsine oxide results in increased expression of HMOX1 protein |
CTD |
PMID:26144063 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
ITIH3 |
inter-alpha-trypsin inhibitor heavy chain 3 |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of ITIH3 mRNA |
CTD |
PMID:17481689 |
|
NCBI chr 3:52,794,796...52,808,797
Ensembl chr 3:52,794,768...52,808,799
|
|
G |
KRT18 |
keratin 18 |
decreases expression |
ISO |
trimethylarsine oxide results in decreased expression of KRT18 mRNA |
CTD |
PMID:17481689 |
|
NCBI chr12:52,948,855...52,952,906
Ensembl chr12:52,948,871...52,952,906
|
|
G |
MAPK14 |
mitogen-activated protein kinase 14 |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of MAPK14 mRNA |
CTD |
PMID:17481689 |
|
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,782...36,111,236
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
decreases expression |
ISO |
trimethylarsine oxide results in decreased expression of MAPK8 mRNA |
CTD |
PMID:17481689 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
EXP |
NFE2L2 mutant form inhibits the reaction [trimethylarsine oxide results in increased expression of NQO1 protein]; trimethylarsine oxide results in increased expression of and affects the localization of NFE2L2 protein |
CTD |
PMID:24161444 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions increases expression |
EXP ISO |
NFE2L2 mutant form inhibits the reaction [trimethylarsine oxide results in increased expression of NQO1 protein]; trimethylarsine oxide promotes the reaction [sulforaphane results in increased expression of and results in increased activity of NQO1 protein]; trimethylarsine oxide promotes the reaction [sulforaphane results in increased expression of NQO1 mRNA]; trimethylarsine oxide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of NQO1 protein]; trimethylarsine oxide promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of NQO1 mRNA]; trimethylarsine oxide results in increased expression of and results in increased activity of NQO1 protein trimethylarsine oxide results in increased expression of NQO1 mRNA; trimethylarsine oxide results in increased expression of NQO1 protein |
CTD |
PMID:24161444 PMID:26042454 PMID:26144063 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
OGG1 |
8-oxoguanine DNA glycosylase |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of OGG1 mRNA |
CTD |
PMID:17481689 |
|
NCBI chr 3:9,749,952...9,783,108
Ensembl chr 3:9,749,944...9,788,219
|
|
G |
PCNA |
proliferating cell nuclear antigen |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of PCNA mRNA |
CTD |
PMID:17481689 |
|
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
|
|
G |
PRKCA |
protein kinase C alpha |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of PRKCA mRNA |
CTD |
PMID:17481689 |
|
NCBI chr17:66,302,613...66,810,743
Ensembl chr17:66,302,613...66,810,743
|
|
G |
PRKCG |
protein kinase C gamma |
increases expression |
ISO |
trimethylarsine oxide results in increased expression of PRKCG mRNA |
CTD |
PMID:17481689 |
|
NCBI chr19:53,881,094...53,907,652
Ensembl chr19:53,879,190...53,907,652
|
|
G |
TNF |
tumor necrosis factor |
decreases secretion |
ISO |
trimethylarsine oxide results in decreased secretion of TNF protein |
CTD |
PMID:9548797 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|